Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 17/20 | 0.72 |
| ▸ | ABCC1 | P33527 | 9/20 | 0.72 |
| ▸ | PIM1 | P11309 | 1/20 | 0.48 |
| ▸ | KDR | P35968 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16303815 | 0.92 | ABCG2 (0.72) | ABCG2ABCC1PIM1KDRKDM4E | |
| SCHEMBL17747440 | 0.92 | ABCG2 (0.82) | ABCG2ABCC1PIM1KDRKDM4E | |
| SCHEMBL17747444 | 0.91 | ABCG2 (0.86) | ABCG2ABCC1PIM1KDRALDH1A1 | |
| SCHEMBL17747473 | 0.90 | ABCG2 (0.72) | ABCG2ABCC1KDM4EALDH1A1CHRM4 | |
| SCHEMBL17747459 | 0.89 | ABCG2 (0.73) | ABCG2ABCC1PIM1KDRMAPT | |
| SCHEMBL17755511 | 0.88 | ABCG2 (0.67) | ABCG2ABCC1PIM1KDRKDM4E | |
| SCHEMBL17747430 | 0.88 | ABCG2 (0.75) | ABCG2ABCC1PIM1KDRCHRM4 | |
| SCHEMBL17747437 | 0.88 | ABCG2 (0.75) | ABCG2ABCC1PIM1KDRALDH1A1 | |
| SCHEMBL17747471 | 0.84 | ABCG2 (0.81) | ABCG2ABCC1KDM4EALDH1A1MAPT | |
| SCHEMBL17747436 | 0.84 | ABCG2 (1.00) | ABCG2ABCC1PIM1KDRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9908893-B2 | Thieno [2,3-b] pyridines as multidrug resistance modulators | LATVIAN INSTITUTE OF ORGANIC SYNTHESIS (LV) | 2018-03-06 | — | — | US | disclosed |
| US-20160137664-A1 | THIENO [2,3-b] PYRIDINES AS MULTIDRUG RESISTANCE MODULATORS | LATVIAN INSTITUTE OF ORGANIC SYNTHESIS (LV) | 2016-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160137664-A1 | THIENO [2,3-b] PYRIDINES AS MULTIDRUG RESISTANCE MODULATORS | ABCC1, ABCB1, MT-CO1 | ABCG2 223/4885ABCC1 1/4885PIM1 2367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.